We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Ovintiv
OVV
$17.6B
| $7.21M | 0.02% |
163,243
-64,987
| -28% | -$3.35M |
|
|
ANSS
727
DELISTED
Ansys
ANSS
| $7.17M | 0.02% |
30,344
-9,446
| -24% | -$2.5M |
|
728
Black Hills Corp
BKH
$5.61B
| $7.16M | 0.02% |
98,764
+62,848
| +175% | +$4.72M |
|
729
Carlisle Companies
CSL
$15.6B
| $7.09M | 0.02% |
30,179
-62,887
| -68% | -$15.7M |
|
730
Frontdoor
FTDR
$5.81B
| $7.08M | 0.02% |
300,730
-299,445
| -50% | -$8.09M |
|
731
Dana Inc
DAN
$3.25B
| $7.04M | 0.02% |
513,695
+160,963
| +46% | +$2.5M |
|
732
LiveRamp
RAMP
$2.3B
| $6.98M | 0.02% |
271,794
+234,859
| +636% | +$6.97M |
|
733
Brixmor Property Group
BRX
$9.11B
| $6.96M | 0.02% |
345,413
+42,851
| +14% | +$1.01M |
|
734
Sylvamo
SLVM
$1.6B
| $6.95M | 0.02% |
213,897
+100,145
| +88% | +$4.2M |
|
735
Hayward Holdings
HAYW
$3.31B
| $6.95M | 0.02% |
489,567
+418,932
| +593% | +$6.46M |
|
736
Raymond James Financial
RJF
$34.6B
| $6.94M | 0.02% |
79,365
-22,245
| -22% | -$2.18M |
|
737
PTC
PTC
$16.3B
| $6.92M | 0.02% |
65,748
+24,581
| +60% | +$2.65M |
|
738
Lear
LEA
$8.13B
| $6.91M | 0.02% |
56,366
-34,461
| -38% | -$4.54M |
|
|
SGEN
739
DELISTED
Seagen Inc. Common Stock
SGEN
| $6.91M | 0.02% |
39,044
-23,031
| -37% | -$3.32M |
|
740
Hilton Worldwide
HLT
$71B
| $6.83M | 0.02% |
62,178
+12,951
| +26% | +$1.79M |
|
|
SGI
741
Somnigroup International
SGI
$13.7B
| $6.82M | 0.02% |
329,675
+167,769
| +104% | +$4.32M |
|
742
Woodward
WWD
$21.1B
| $6.82M | 0.02% |
75,306
+53,879
| +251% | +$5.61M |
|
743
Globe Life
GL
$14.2B
| $6.74M | 0.02% |
69,989
+31,450
| +82% | +$3.08M |
|
744
Live Nation Entertainment
LYV
$42.9B
| $6.73M | 0.02% |
82,749
-165,113
| -67% | -$15.9M |
|
745
Paycom
PAYC
$9.55B
| $6.71M | 0.02% |
24,314
-14,597
| -38% | -$4.31M |
|
746
Verisk Analytics
VRSK
$23.5B
| $6.63M | 0.02% |
38,987
-2,921
| -7% | -$545K |
|
747
Dr. Reddy's Laboratories
RDY
$10.4B
| $6.62M | 0.02% |
597,640
-92,730
| -13% | -$1.01M |
|
|
CALY
748
Callaway Golf Company
CALY
$3.04B
| $6.6M | 0.01% |
335,472
+68,115
| +25% | +$1.46M |
|
749
Element Solutions
ESI
$9.17B
| $6.57M | 0.01% |
376,970
+125,659
| +50% | +$2.55M |
|
750
Community Health Systems
CYH
$402M
| $6.57M | 0.01% |
1,750,920
+1,485,122
| +559% | +$10.5M |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.